1-3 of 3
Stuart Osborne
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Subcutaneous or Intravenous Administration of Rituximab in Patients with CD20+ Diffuse Large B-Cell Lymphoma or Follicular Lymphoma: Final Results of the Randomized, Open-Label, Crossover, PrefMab Study

Mathias J Rummel, Tae Min Kim, Franco Aversa, MD, Wolfram Brugger, MDPhD, Enrico Capochiani, Caterina Plenteda, Francesca Re, Peter Task, Christine McIntyre, Oliver Meier, Stuart Osborne, Rodney Smith, Andrew Grigg, MBBS FRACP FRCPA
Journal: Blood
Blood (2017) 130 (Supplement 1): 2834.
https://doi.org/10.1182/blood.V130.Suppl_1.2834.2834
Published: 2017
Journal Articles

Prefmab: Final Analysis of Patient Preference for Subcutaneous Versus Intravenous Rituximab in Previously Untreated CD20+ Diffuse Large B-Cell Lymphoma and Follicular Lymphoma

Mathias Rummel, MD PhD, Tae Min Kim, MD PhD, Caterina Plenteda, MD, Enrico Capochiani, MD, Maria Mendoza, Rodney Smith, MD PhD, Stuart Osborne, MSc, Andrew Grigg, MBBS, MD FRACP, FRACPA
Journal: Blood
Blood (2015) 126 (23): 3972.
https://doi.org/10.1182/blood.V126.23.3972.3972
Published: 2015
Journal Articles

A Randomized Comparison Of Maintenance Therapy With Subcutaneous Rituximab For 2 Years Versus Until Progression In Patients With Indolent Non-Hodgkin’s Lymphoma: Interim Safety Data From The Mabcute Study

Simon Rule, MD, Javier Briones, MD, Angelo Michele Carella, MD, Olivier Casasnovas, MD, Wolney Gois Barreto, MD, Christopher Pocock, PhD, Stuart Osborne, PhD, Rodney Smith, MD, Francesco Zaja, MD
Journal: Blood
Blood (2013) 122 (21): 3052.
https://doi.org/10.1182/blood.V122.21.3052.3052
Published: 2013